BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

FDA Approves Autolus’s CAR-T Therapy Aucatzyl for Relapsed or Refractory B-ALL in Adults

Home
/
update
/
details

SigTuple Secures $4 Million in Extended Series C Funding Led by SIDBI Venture Capital

NextEdge Admin

07 Aug 2024

1 min 52 sec

Medtech startup SigTuple has secured Rs 33 crore ($4 million) in an extended Series C round led by SIDBI Venture Capital, along with contributions from existing investors such as Endiya Partners and strategic healthcare leaders. This follows a previous $4.3 million Series C round in March 2023, led by Endiya Partners and Accel, bringing the Bengaluru-based company’s total funding to over $40 million.

Founded in 2015 by Apurv Anand, Bharath Cheluvaraju, Rohit Kumar Pandey, and Tathagato Dastidar, SigTuple specializes in AI-driven smart robotic microscopes that automate manual processes in clinical laboratories. Since 2020, the company has focused on its flagship product, AI100, which has seen significant adoption among major diagnostics industry players in India.

The latest funding will support SigTuple’s geographical expansion, product portfolio enhancement, and regulatory clearances. The company has partnered with Horiba Medical for distribution in South Asia and has extended its reach to Southeast Asia, the Middle East, and North Africa, with plans to enter Europe and the Americas. In September 2023, AI100 received US FDA 510(k) approval, making SigTuple the third company globally—and the first in India—to achieve this for AI-assisted digital haematology.